Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
Abstract Background Ovarian cancer (OC) is a gynecological malignancy with a high mortality. Cisplatin-based treatment is the typical treatment regimen for OC patients; however, it may cause unfavorable resistance. The current study intends to explore the function of cancer-associated fibroblast (CA...
Main Authors: | Hua Guo, Chunfang Ha, Hui Dong, Zhijuan Yang, Yuan Ma, Yonghui Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-019-1051-3 |
Similar Items
-
Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5
by: Xing Qin, et al.
Published: (2019-01-01) -
BNIP3 contributes to cisplatin‐induced apoptosis in ovarian cancer cells
by: Jinghui Jia, et al.
Published: (2020-08-01) -
Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
by: Fengming Yang, et al.
Published: (2017-08-01) -
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
by: Li Liu, et al.
Published: (2019-07-01) -
Advancement of Cancer Associated Fibroblasts-derived Exosomes in Lung Cancer
by: Cheng SHEN, et al.
Published: (2021-03-01)